Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What is Multicell Technologies' stake with an average unit sales of 20,000 units and an average price of $ 631 dollars per year???
For example: 20,000 units * $631 dollars = $12,620,000 dollars per year.
$MCET Question: How many units of the drugs are sold to hospitals each year? US and Europe / Germany patents have approximately 8146 hospitals in total.
There are around 2.000 hospitals (Krankenhäuser) in Germany. https://www.iamexpat.de/expat-info/german-healthcare-system/hospitals-germany#:~:text=There%20are%20around%202.000%20hospitals,of%20health%20insurance%20you%20have.
Total Number of All U.S. Hospitals 6,146 https://www.aha.org/statistics/fast-facts-us-hospitals
$631 Dollar average price of 6 drugs https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161097767
$MCET Question: How many units of the drugs are sold to hospitals each year? US and Europe / Germany patents have approximately 8146 hospitals in total.
There are around 2.000 hospitals (Krankenhäuser) in Germany. https://www.iamexpat.de/expat-info/german-healthcare-system/hospitals-germany#:~:text=There%20are%20around%202.000%20hospitals,of%20health%20insurance%20you%20have.
Total Number of All U.S. Hospitals 6,146 https://www.aha.org/statistics/fast-facts-us-hospitals
$631 Dollar average price of 6 drugs https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161097767
Market Makers on radar! LONG confirmed! More and More VOLUME! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Market Makers on radar! LONG confirmed! More and More VOLUME! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Seven Patents Active: Multicell Technologies, Rhode Island Hospital and Xenotech ( SEKISUI XenoTech )
One Patent Multicell Technologies Receives Stem Cell Patent Active!
Inventor: Ronald A. Faris
Current Assignee: Rhode Island Hospital
US7935528 B2
Application granted
Status Active
2022-10-21 Adjusted expiration
https://patents.google.com/patent/US7935528B2/en?oq=7%2c935%2c528
The invention provides a primary liver stem cell and a cell doublet consisting of a hepatocyte and the stem cell, both of which are derived from normal liver tissue. Methods of isolating the cells, genetically altering the cells, and using the cells for transplantation are also within the invention.
https://www.patentdocs.org/2011/07/patent-profile-multicell-technologies-receives-stem-cell-patent.html
Six Fa2N-4 Multicell Technologies / Xenotech Patents Active!
Inventor: Jin LiuRonald A. Faris
Current Assignee: Multicell Technologies
US 7566567 B2 Immortalized hepatocytes
Application granted
Status Active
2025-01-13 Adjusted expiration
https://patents.google.com/patent/US7566567B2/en?oq=7%2c566%2c567
Inventor: Jin Liu, Ronald A. Faris
Current Assignee: Multicell Technologies
EP 1704227 B1 IMMORTALIZED HEPATOCYTES
Doc Type: Granted Patent
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227B1/en?oq=EP1704227B1
Inventor: Jin Liu, Ronald A Faris
Current Assignee: Multicell Technologies Inc
EP1704227 A4 IMMORTALIZED HEPATOCYTES
Application granted
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227A4/en?oq=EP1704227A4
Inventor: Jin Liu, Ronald A Faris
Current Assignee: Multicell Technologies Inc
EP1704227 A1 IMMORTALIZED HEPATOCYTES
Application granted
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227A1/en?oq=EP1704227A1
Inventor: Jin LiuRonald A. Faris
Current Assignee: Multicell Technologies
DE 602004025380 D1 IMMORTALISIERTE HEPATOZYTEN
Doc Type: Granted Patent
Status Active
2024-10-08 Anticipated expiration
https://patents.google.com/patent/DE602004025380D1/en?oq=DE602004025380
Inventor: Jin LiuRonald Farie
Current Assignee: Multicell Technologies Inc
US20070004039 A1 Immortalized hepatocytes
2009-07-28 Application granted
Status Active
2025-01-13 Adjusted expiration
https://patents.google.com/patent/US20070004039A1/en?oq=US20070004039A1
Family timeline https://www.lens.org/lens/patent/167-627-709-236-287/family
Immortalized Hepatocytes https://www.lens.org/lens/patent/167-627-709-236-28
$GSFI Green Stream Holdings Anticipates Sunny Forecast for Renewable Energy - Market Rally as U.S. Stocks Soar Just Hours Before Biden Inauguration
JAN 20, 2021 11:59AM EST
Malibu, California--(Newsfile Corp. - January 20, 2021) - Green Stream Holdings Inc. (OTC PINK: GSFI) ("the Company") ("Green Stream") (http://www.GreenRainSolar.com ), an emerging leader in the solar utility and finance space, announces today what it believes to be a new era for Renewable Energy and its Solar Utilities/Financing model as stocks rise in advance of the inauguration of Joe Biden as the 46th President of the United States.
To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_002full.jpg
Biden's agenda is to transition the U.S. from an economy reliant on fossil fuels to one driven by wind, solar and other renewable-energy sources. The shift from fossil-fuel companies to renewable-energy firms accelerated during the Trump administration, despite the president's vows to support the U.S. coal and petroleum industries.
Big and small investors have moved their assets away from fossil-fuel producers and toward renewable energy companies. Big investors like BlackRock Inc., the world's largest asset manager, overseeing $7.8 trillion, have said they plan to take into account corporations' disclosures of environmental risks, including carbon footprints.
According to Wells Fargo senior market strategist Scott Wren, "Since the start of the year, cyclicals have outperformed, with energy gaining the most, up 15%, helped by higher oil prices. Financials were up 5.1%, and materials were up 4.4%."
"All of these cyclicals stocks have moved in advance of what we think will be a higher rate move. Rates have moved up to support that idea," Wilson said. "We think they could go up quite a bit more over the course of the next several months."
As well, The iShares Global Clean Energy ETF, which tracks S&P Global's index of clean energy companies around the world, has risen by nearly 30% since July 2020. The fund's assets under management swelled to $1.2 billion from $431 million at the start of the year.
GSFI CEO Eric Fain is encouraged by the increased opportunity Biden's new agenda could mean for companies like Green Stream Holdings. "I believe we are at the dawn of a new era for renewable energy and, in turn, an increased access to market with ability to expedite shareholder value as we cultivate new opportunities alongside our current projects in New York, including:
160 Imlay street. Brooklyn Ny
8012 Tonelle Ave; North Bergen, NJ
44 Victory Blvd; Staten Island, NY
111 Station Road; Bellport, NY
15-17 Sherwood Ave - Yonkers Proposal
4290 Austin Blvd; Island Park, NY
"We have recently moved our headquarters to a functional work/living space which belongs to our flagship project at 160 Imlay Street in Brooklyn, New York, where our utility/financing model can be seen in action as we continue to develop opportunities in the NE United States and beyond."
Project To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_003full.jpg
"This is all in line with NY Governor Cuomo's recent announcement of a clean energy initiative which unveiled the details of the awards for 21 large-scale solar, wind, and energy storage projects across upstate New York, totaling 1,278 megawatts of new renewable capacity," states Fain.
Shareholders-visit greenrainsolar.com. where you can view Green Stream's news, filings and even a live Level 2 stream, along with other company information.
Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004.jpg GSFI - Strategic Moves To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004full.jpg
https://www.nasdaq.com/press-release/green-stream-holdings-anticipates-sunny-forecast-for-renewable-energy-market-rally-as
$GSFI Green Stream Holdings Anticipates Sunny Forecast for Renewable Energy - Market Rally as U.S. Stocks Soar Just Hours Before Biden Inauguration
JAN 20, 2021 11:59AM EST
Malibu, California--(Newsfile Corp. - January 20, 2021) - Green Stream Holdings Inc. (OTC PINK: GSFI) ("the Company") ("Green Stream") (http://www.GreenRainSolar.com ), an emerging leader in the solar utility and finance space, announces today what it believes to be a new era for Renewable Energy and its Solar Utilities/Financing model as stocks rise in advance of the inauguration of Joe Biden as the 46th President of the United States.
To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_002full.jpg
Biden's agenda is to transition the U.S. from an economy reliant on fossil fuels to one driven by wind, solar and other renewable-energy sources. The shift from fossil-fuel companies to renewable-energy firms accelerated during the Trump administration, despite the president's vows to support the U.S. coal and petroleum industries.
Big and small investors have moved their assets away from fossil-fuel producers and toward renewable energy companies. Big investors like BlackRock Inc., the world's largest asset manager, overseeing $7.8 trillion, have said they plan to take into account corporations' disclosures of environmental risks, including carbon footprints.
According to Wells Fargo senior market strategist Scott Wren, "Since the start of the year, cyclicals have outperformed, with energy gaining the most, up 15%, helped by higher oil prices. Financials were up 5.1%, and materials were up 4.4%."
"All of these cyclicals stocks have moved in advance of what we think will be a higher rate move. Rates have moved up to support that idea," Wilson said. "We think they could go up quite a bit more over the course of the next several months."
As well, The iShares Global Clean Energy ETF, which tracks S&P Global's index of clean energy companies around the world, has risen by nearly 30% since July 2020. The fund's assets under management swelled to $1.2 billion from $431 million at the start of the year.
GSFI CEO Eric Fain is encouraged by the increased opportunity Biden's new agenda could mean for companies like Green Stream Holdings. "I believe we are at the dawn of a new era for renewable energy and, in turn, an increased access to market with ability to expedite shareholder value as we cultivate new opportunities alongside our current projects in New York, including:
160 Imlay street. Brooklyn Ny
8012 Tonelle Ave; North Bergen, NJ
44 Victory Blvd; Staten Island, NY
111 Station Road; Bellport, NY
15-17 Sherwood Ave - Yonkers Proposal
4290 Austin Blvd; Island Park, NY
"We have recently moved our headquarters to a functional work/living space which belongs to our flagship project at 160 Imlay Street in Brooklyn, New York, where our utility/financing model can be seen in action as we continue to develop opportunities in the NE United States and beyond."
Project To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_003full.jpg
"This is all in line with NY Governor Cuomo's recent announcement of a clean energy initiative which unveiled the details of the awards for 21 large-scale solar, wind, and energy storage projects across upstate New York, totaling 1,278 megawatts of new renewable capacity," states Fain.
Shareholders-visit greenrainsolar.com. where you can view Green Stream's news, filings and even a live Level 2 stream, along with other company information.
Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004.jpg GSFI - Strategic Moves To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004full.jpg
https://www.nasdaq.com/press-release/green-stream-holdings-anticipates-sunny-forecast-for-renewable-energy-market-rally-as
Market Makers decide! It's going up! Purchase offers confirmed! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Market Makers decide! It's going up! Purchase offers confirmed! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
PATENT INFORMATION
======================================
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=86202825
Patent Portfolio of MultiCell Technologies, Inc., MultiCell Immunotherapeutics and majority-owned subsidiary, Xenogenics. Patents already published which can be found in the public domain.
MultiCell Technologies, Inc.
US Patent 6,737,057: Compounds, compositions and methods for the Endocytic presentation of immunosuppressive factors
US Patent 6,129,911: Liver stem cell
US Patent 6,872,389: Liver stem cell
US Patent 6,017,760: Isolation and culture of porcine hepatocytes
US Patent 6,107,043: Immortalized hepatocytes
US Patent 5,043,260: Perfusion device with hepatocytes
US Patent 4,795,459: Implantable Prosthetic Device (endothelial)
US Patent 6,858,146: Artificial Liver Apparatus and Method (Trademarked as the SybiolR synthetic bio-liver)
US Patent 7,935,528 The invention provides a primary liver stem cell and a cell doublet consisting of a hepatocyte and the stem cell, both of which are derived from normal liver tissue. Methods of isolating the cells, genetically altering the cells, and using the cells for transplantation are also within the invention.
US Patent 7,566,567: Immortalized hepatocytes
US20070104696A1: Use of cell lines to produce active therapeutic proteins
US20070004039A1: Immortalized hepatocytes
EP1704227B1:
IMMORTALIZED HEPATOCYTES
DE602004025380C0: IMMORTALISIERTE HEPATOZYTEN
AT0456376E: IMMORTALISIERTE HEPATOZYTEN
AU8229981A1: Immortalized hepatocytes
AU4322811AH: Immortalized hepatocytes
EP1704227A4: IMMORTALIZED HEPATOCYTES
WO06041488C1: IMMORTALIZED HEPATOCYTES
WO06041488A1: IMMORTALIZED HEPATOCYTES
IL0174787A0: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
EP1685252A4: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
EP1704227A1: IMMORTALIZED HEPATOCYTES
EP1685252A2: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
CA2550452A1 IMMORTALIZED HEPATOCYTES
AU4322811A1 Immortalized hepatocytes
WO05034876A3 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
WO05034876A2 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
CA2541380A1 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
AU4280238AB Use of cell lines to produce active therapeutic proteins
AU4280238A1 Use of cell lines to produce active therapeutic proteins
Xenogenics.
When Xenogenics acquired the assets of Bioabsorbable Therapeutics, Inc., it acquired and continues to support issued U.S. patent 7,674,285: Polyanhydride polymers and their uses in biomedical devices. This process is incorporated in and trademarked as the Ideal Bio-StentR.
MultiCell ImmunoTherapeutics.
Below is a listing of the intellectual properties of which Astral, Inc. is the Assignee. This intellectual property is now owned by MultiCell Immunotherapeutics resulting from the purchase agreement between MultiCell Technologies, Inc. and Alliance Pharmaceuticals, Inc.
US20120189645A1:COMPOSITIONS AND METHODS TO TREAT AND CONTROL TUMORS.
CN100376594C: DOUBLE-CHAIN RNA AND METHOD TO INITIATE, ENHANCE OR ADJUST IMMUNOMODULATORY OR IMMUNE RESPONSE.
CN1795274A: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
CN1780848A: COMPOSITIONS AND METHODS TO INITIATE OR ENHANCE ANTIBODY AND
MAJOR-HISTOCOMPATIBILITY CLASS I OR CLASS II-RESTRICTED T CELL RESPONSES BY
USING IMMUNOMODULATORY, NON-CODING RNA MOTIFS.
WO04087877A3: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
CN1703427A: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS .
WO04087877A2: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
WO04027049B1: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
WO04027049A3: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
WO03078595B1: IMMUNOSTIMULATORY DOUBLE STRANDED RNA AND METHODS OF INDUCING, ENHANCING OR MODULATING THE IMMUNE RESPONSE.
WO04027049A2: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
WO03078595A3: IMMUNOSTIMULATORY DOUBLE STRANDED RNA AND METHODS OF INDUCING, ENHANCING OR MODULATING THE IMMUNE RESPONSE.
CA2520181A1: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
CA2499066A1: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
AU4225480A1: SELECTED RNA MOTIFS TO INCLUDE CELL DEATH AND/OR APOPTOSIS.
AU3276932A1: METHODS AND COMPOSITIONS TO GENERATE AND CONTROL THE EFFECTOR PROFILE OF TCELLS BY SIMULTANEOUS LOADING AND ACTIVATION OF SELECTED SUBSETS OF ANTIGEN PRESENTING CELLS.
WO03078595A2: COMPOSITIONS AND METHODS TO INITIATE OR ENHANCE ANTIBODY AND MAJOR-HISTOCOMPATIBILITY CLASS I OR CLASS II-RESTRICTED T CELL RESPONSES BY
USING IMMUNOMODULATORY, NON-CODING RNA MOTIFS.
CA2479187A1: IMMUNOSTIMULATORY DOUBLE STRANDED RNA AND METHODS OF INDUCING, ENHANCING OR MODULATING THE IMMUNE RESPONSE.
AU3218181A1: COMPOSITIONS AND METHODS TO INITIATE OR ENHANCE ANTIBODY AND MAJOR-HISTOCOMPATIBILITY CLASS I OR CLASS II-RESTRICTED T CELL RESPONSES BY USING IMMUNOMODULATORY, NON-CODING RNA MOTIFS.
US7566567: Immortalized hepatocytes
US20070104696A1: Use of cell lines to produce active therapeutic proteins
US20070004039A1: Immortalized hepatocytes
EP1704227B1:
IMMORTALIZED HEPATOCYTES
DE602004025380C0: IMMORTALISIERTE HEPATOZYTEN
AT0456376E: IMMORTALISIERTE HEPATOZYTEN
AU8229981A1: Immortalized hepatocytes
AU4322811AH: Immortalized hepatocytes
EP1704227A4: IMMORTALIZED HEPATOCYTES
WO06041488C1: IMMORTALIZED HEPATOCYTES
WO06041488A1: IMMORTALIZED HEPATOCYTES
IL0174787A0: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
EP1685252A4: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
EP1704227A1: IMMORTALIZED HEPATOCYTES
EP1685252A2: USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
CA2550452A1 IMMORTALIZED HEPATOCYTES
AU4322811A1 Immortalized hepatocytes
WO05034876A3 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
WO05034876A2 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
CA2541380A1 USE OF CELL LINES TO PRODUCE ACTIVE THERAPEUTIC PROTEINS
AU4280238AB Use of cell lines to produce active therapeutic proteins
AU4280238A1 Use of cell lines to produce active therapeutic proteins
$MCET Please read! Multicell Technologies has the money, gives the money to Eide Bailly LLP, Eide Bailly LLP buys shares and it goes up. Or! Multicell Technologies needs money, Eide Bailly LLP is selling shares and the price is falling.
$MCET Please read! Multicell Technologies has the money, gives the money to Eide Bailly LLP, Eide Bailly LLP buys shares and it goes up. Or! Multicell Technologies needs money, Eide Bailly LLP is selling shares and the price is falling.
$MCET Seven Patents Active: Multicell Technologies, Rhode Island Hospital and Xenotech ( SEKISUI XenoTech )
One Patent Multicell Technologies Receives Stem Cell Patent Active!
Inventor: Ronald A. Faris
Current Assignee: Rhode Island Hospital
US7935528 B2
Application granted
Status Active
2022-10-21 Adjusted expiration
https://patents.google.com/patent/US7935528B2/en?oq=7%2c935%2c528
The invention provides a primary liver stem cell and a cell doublet consisting of a hepatocyte and the stem cell, both of which are derived from normal liver tissue. Methods of isolating the cells, genetically altering the cells, and using the cells for transplantation are also within the invention.
https://www.patentdocs.org/2011/07/patent-profile-multicell-technologies-receives-stem-cell-patent.html
Six Fa2N-4 Multicell Technologies / Xenotech Patents Active!
Inventor: Jin LiuRonald A. Faris
Current Assignee: Multicell Technologies
US 7566567 B2 Immortalized hepatocytes
Application granted
Status Active
2025-01-13 Adjusted expiration
https://patents.google.com/patent/US7566567B2/en?oq=7%2c566%2c567
Inventor: Jin Liu, Ronald A. Faris
Current Assignee: Multicell Technologies
EP 1704227 B1 IMMORTALIZED HEPATOCYTES
Doc Type: Granted Patent
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227B1/en?oq=EP1704227B1
Inventor: Jin Liu, Ronald A Faris
Current Assignee: Multicell Technologies Inc
EP1704227 A4 IMMORTALIZED HEPATOCYTES
Application granted
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227A4/en?oq=EP1704227A4
Inventor: Jin Liu, Ronald A Faris
Current Assignee: Multicell Technologies Inc
EP1704227 A1 IMMORTALIZED HEPATOCYTES
Application granted
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227A1/en?oq=EP1704227A1
Inventor: Jin LiuRonald A. Faris
Current Assignee: Multicell Technologies
DE 602004025380 D1 IMMORTALISIERTE HEPATOZYTEN
Doc Type: Granted Patent
Status Active
2024-10-08 Anticipated expiration
https://patents.google.com/patent/DE602004025380D1/en?oq=DE602004025380
Inventor: Jin LiuRonald Farie
Current Assignee: Multicell Technologies Inc
US20070004039 A1 Immortalized hepatocytes
2009-07-28 Application granted
Status Active
2025-01-13 Adjusted expiration
https://patents.google.com/patent/US20070004039A1/en?oq=US20070004039A1
Family timeline https://www.lens.org/lens/patent/167-627-709-236-287/family
Immortalized Hepatocytes https://www.lens.org/lens/patent/167-627-709-236-28
$MCET Seven Patents Active: Multicell Technologies, Rhode Island Hospital and Xenotech ( SEKISUI XenoTech )
One Patent Multicell Technologies Receives Stem Cell Patent Active!
Inventor: Ronald A. Faris
Current Assignee: Rhode Island Hospital
US7935528 B2
Application granted
Status Active
2022-10-21 Adjusted expiration
https://patents.google.com/patent/US7935528B2/en?oq=7%2c935%2c528
The invention provides a primary liver stem cell and a cell doublet consisting of a hepatocyte and the stem cell, both of which are derived from normal liver tissue. Methods of isolating the cells, genetically altering the cells, and using the cells for transplantation are also within the invention.
https://www.patentdocs.org/2011/07/patent-profile-multicell-technologies-receives-stem-cell-patent.html
Six Fa2N-4 Multicell Technologies / Xenotech Patents Active!
Inventor: Jin LiuRonald A. Faris
Current Assignee: Multicell Technologies
US 7566567 B2 Immortalized hepatocytes
Application granted
Status Active
2025-01-13 Adjusted expiration
https://patents.google.com/patent/US7566567B2/en?oq=7%2c566%2c567
Inventor: Jin Liu, Ronald A. Faris
Current Assignee: Multicell Technologies
EP 1704227 B1 IMMORTALIZED HEPATOCYTES
Doc Type: Granted Patent
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227B1/en?oq=EP1704227B1
Inventor: Jin Liu, Ronald A Faris
Current Assignee: Multicell Technologies Inc
EP1704227 A4 IMMORTALIZED HEPATOCYTES
Application granted
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227A4/en?oq=EP1704227A4
Inventor: Jin Liu, Ronald A Faris
Current Assignee: Multicell Technologies Inc
EP1704227 A1 IMMORTALIZED HEPATOCYTES
Application granted
Status Active
2024-10-07 Anticipated expiration
https://patents.google.com/patent/EP1704227A1/en?oq=EP1704227A1
Inventor: Jin LiuRonald A. Faris
Current Assignee: Multicell Technologies
DE 602004025380 D1 IMMORTALISIERTE HEPATOZYTEN
Doc Type: Granted Patent
Status Active
2024-10-08 Anticipated expiration
https://patents.google.com/patent/DE602004025380D1/en?oq=DE602004025380
Inventor: Jin LiuRonald Farie
Current Assignee: Multicell Technologies Inc
US20070004039 A1 Immortalized hepatocytes
2009-07-28 Application granted
Status Active
2025-01-13 Adjusted expiration
https://patents.google.com/patent/US20070004039A1/en?oq=US20070004039A1
Family timeline https://www.lens.org/lens/patent/167-627-709-236-287/family
Immortalized Hepatocytes https://www.lens.org/lens/patent/167-627-709-236-28
U.S. Companies Developing RNA-targeted Therapies
Presentation PanHellenic Congress of Cardiology Oct 18, 2019
microRNA and Other Nucleic Acid = Multicell Technologies,...
https://static.livemedia.gr/services/hcs/userfiles/usid0_20191018064742_1tsimikas064741.pdf
$MCET 8s! Please Read! Great Multicell Technologies Article from Journal of Nanobiotechnology!
Treatment of breast cancer with autophagy inhibitory microRNAs carried by AGO2-conjugated nanoparticles
28 April 2020
Materials and methods
... Ethylenediaminetetraacetic acid (EDTA) disodium salt was purchased from Multicell (U.S.A.)...
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-020-00615-4
https://jnanobiotechnology.biomedcentral.com/track/pdf/10.1186/s12951-020-00615-4.pdf
$MCET Please Read! Great Multicell Technologies Article from Journal of Nanobiotechnology!
Treatment of breast cancer with autophagy inhibitory microRNAs carried by AGO2-conjugated nanoparticles
28 April 2020
Materials and methods
... Ethylenediaminetetraacetic acid (EDTA) disodium salt was purchased from Multicell (U.S.A.)...
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-020-00615-4
https://jnanobiotechnology.biomedcentral.com/track/pdf/10.1186/s12951-020-00615-4.pdf
Please Read! Great Multicell Technologies Article from Journal of Nanobiotechnology!
Treatment of breast cancer with autophagy inhibitory microRNAs carried by AGO2-conjugated nanoparticles
28 April 2020
Materials and methods
... Ethylenediaminetetraacetic acid (EDTA) disodium salt was purchased from Multicell (U.S.A.)...
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-020-00615-4
https://jnanobiotechnology.biomedcentral.com/track/pdf/10.1186/s12951-020-00615-4.pdf
$MCET Should play MMs, i have a very long time! $$$$$$$$$$$$$$$$$$$
Should play MMs, i have a very long time. LONG $MCET!
$MCET 0.001 Seven Patents active! Multi Bagger GAIN $$$$$
$MCET 0.001 Seven Patents active! Multi Bagger GAIN $$$$$
LA JOLLA COVE INVESTORS, INC earns very well! They have Outstanding Shares OS 499,594,775 9.99% from MCET Multicell Technologies.
2019-02-14
https://www.sec.gov/Archives/edgar/data/811779/000114420419007520/tv513409_sc13ga.htm
Multicell Technologies decides! >>> https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161183812
MultiCell Technologies says where to go! >>> https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161223308
$MCET These Patents are then worth $1.75 Dollar per share, according to analysts? WOOOOOW https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161239175
Analyst Confirmation!!
https://www.marketwatch.com/investing/stock/mcet/analystestimates?mod=mw_quote_analyst
https://money.cnn.com/quote/forecast/forecast.html?symb=MCET
$MCET These Patents are then worth $1.75 Dollar per share, according to analysts? WOOOOOW https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161239175
Analyst Confirmation!!
https://www.marketwatch.com/investing/stock/mcet/analystestimates?mod=mw_quote_analyst
https://money.cnn.com/quote/forecast/forecast.html?symb=MCET
These Patents are then worth $1.75 Dollar per share, according to analysts? WOOOOOW https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161239175
STOCK PRICE TARGETS also confirmed at marketwatch. https://www.marketwatch.com/investing/stock/mcet/analystestimates?mod=mw_quote_analyst
$MCET Question: How many units of the drugs are sold to hospitals each year? US and Europe / Germany patents have approximately 8146 hospitals in total.
There are around 2.000 hospitals (Krankenhäuser) in Germany. https://www.iamexpat.de/expat-info/german-healthcare-system/hospitals-germany#:~:text=There%20are%20around%202.000%20hospitals,of%20health%20insurance%20you%20have.
Total Number of All U.S. Hospitals 6,146 https://www.aha.org/statistics/fast-facts-us-hospitals
$631 Dollar average price of 6 drugs https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161097767
$MCET Question: How many units of the drugs are sold to hospitals each year? US and Europe / Germany patents have approximately 8146 hospitals in total.
There are around 2.000 hospitals (Krankenhäuser) in Germany. https://www.iamexpat.de/expat-info/german-healthcare-system/hospitals-germany#:~:text=There%20are%20around%202.000%20hospitals,of%20health%20insurance%20you%20have.
Total Number of All U.S. Hospitals 6,146 https://www.aha.org/statistics/fast-facts-us-hospitals
$631 Dollar average price of 6 drugs https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161097767
Question: How many units of the drugs are sold to hospitals each year? US and Europe / Germany patents have approximately 8146 hospitals in total.
There are around 2.000 hospitals (Krankenhäuser) in Germany. https://www.iamexpat.de/expat-info/german-healthcare-system/hospitals-germany#:~:text=There%20are%20around%202.000%20hospitals,of%20health%20insurance%20you%20have.
Total Number of All U.S. Hospitals 6,146 https://www.aha.org/statistics/fast-facts-us-hospitals
$631 Dollar average price of 6 drugs https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161097767
Next Step hit up! Its coming! Market Makers confirm! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Next Step hit up! Its coming! Market Makers confirm! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
$GSFI Green Stream Holdings Anticipates Sunny Forecast for Renewable Energy - Market Rally as U.S. Stocks Soar Just Hours Before Biden Inauguration
JAN 20, 2021 11:59AM EST
Malibu, California--(Newsfile Corp. - January 20, 2021) - Green Stream Holdings Inc. (OTC PINK: GSFI) ("the Company") ("Green Stream") (http://www.GreenRainSolar.com ), an emerging leader in the solar utility and finance space, announces today what it believes to be a new era for Renewable Energy and its Solar Utilities/Financing model as stocks rise in advance of the inauguration of Joe Biden as the 46th President of the United States.
To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_002full.jpg
Biden's agenda is to transition the U.S. from an economy reliant on fossil fuels to one driven by wind, solar and other renewable-energy sources. The shift from fossil-fuel companies to renewable-energy firms accelerated during the Trump administration, despite the president's vows to support the U.S. coal and petroleum industries.
Big and small investors have moved their assets away from fossil-fuel producers and toward renewable energy companies. Big investors like BlackRock Inc., the world's largest asset manager, overseeing $7.8 trillion, have said they plan to take into account corporations' disclosures of environmental risks, including carbon footprints.
According to Wells Fargo senior market strategist Scott Wren, "Since the start of the year, cyclicals have outperformed, with energy gaining the most, up 15%, helped by higher oil prices. Financials were up 5.1%, and materials were up 4.4%."
"All of these cyclicals stocks have moved in advance of what we think will be a higher rate move. Rates have moved up to support that idea," Wilson said. "We think they could go up quite a bit more over the course of the next several months."
As well, The iShares Global Clean Energy ETF, which tracks S&P Global's index of clean energy companies around the world, has risen by nearly 30% since July 2020. The fund's assets under management swelled to $1.2 billion from $431 million at the start of the year.
GSFI CEO Eric Fain is encouraged by the increased opportunity Biden's new agenda could mean for companies like Green Stream Holdings. "I believe we are at the dawn of a new era for renewable energy and, in turn, an increased access to market with ability to expedite shareholder value as we cultivate new opportunities alongside our current projects in New York, including:
160 Imlay street. Brooklyn Ny
8012 Tonelle Ave; North Bergen, NJ
44 Victory Blvd; Staten Island, NY
111 Station Road; Bellport, NY
15-17 Sherwood Ave - Yonkers Proposal
4290 Austin Blvd; Island Park, NY
"We have recently moved our headquarters to a functional work/living space which belongs to our flagship project at 160 Imlay Street in Brooklyn, New York, where our utility/financing model can be seen in action as we continue to develop opportunities in the NE United States and beyond."
Project To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_003full.jpg
"This is all in line with NY Governor Cuomo's recent announcement of a clean energy initiative which unveiled the details of the awards for 21 large-scale solar, wind, and energy storage projects across upstate New York, totaling 1,278 megawatts of new renewable capacity," states Fain.
Shareholders-visit greenrainsolar.com. where you can view Green Stream's news, filings and even a live Level 2 stream, along with other company information.
Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004.jpg GSFI - Strategic Moves To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004full.jpg
https://www.nasdaq.com/press-release/green-stream-holdings-anticipates-sunny-forecast-for-renewable-energy-market-rally-as
$GSFI Green Stream Holdings Anticipates Sunny Forecast for Renewable Energy - Market Rally as U.S. Stocks Soar Just Hours Before Biden Inauguration
JAN 20, 2021 11:59AM EST
Malibu, California--(Newsfile Corp. - January 20, 2021) - Green Stream Holdings Inc. (OTC PINK: GSFI) ("the Company") ("Green Stream") (http://www.GreenRainSolar.com ), an emerging leader in the solar utility and finance space, announces today what it believes to be a new era for Renewable Energy and its Solar Utilities/Financing model as stocks rise in advance of the inauguration of Joe Biden as the 46th President of the United States.
To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_002full.jpg
Biden's agenda is to transition the U.S. from an economy reliant on fossil fuels to one driven by wind, solar and other renewable-energy sources. The shift from fossil-fuel companies to renewable-energy firms accelerated during the Trump administration, despite the president's vows to support the U.S. coal and petroleum industries.
Big and small investors have moved their assets away from fossil-fuel producers and toward renewable energy companies. Big investors like BlackRock Inc., the world's largest asset manager, overseeing $7.8 trillion, have said they plan to take into account corporations' disclosures of environmental risks, including carbon footprints.
According to Wells Fargo senior market strategist Scott Wren, "Since the start of the year, cyclicals have outperformed, with energy gaining the most, up 15%, helped by higher oil prices. Financials were up 5.1%, and materials were up 4.4%."
"All of these cyclicals stocks have moved in advance of what we think will be a higher rate move. Rates have moved up to support that idea," Wilson said. "We think they could go up quite a bit more over the course of the next several months."
As well, The iShares Global Clean Energy ETF, which tracks S&P Global's index of clean energy companies around the world, has risen by nearly 30% since July 2020. The fund's assets under management swelled to $1.2 billion from $431 million at the start of the year.
GSFI CEO Eric Fain is encouraged by the increased opportunity Biden's new agenda could mean for companies like Green Stream Holdings. "I believe we are at the dawn of a new era for renewable energy and, in turn, an increased access to market with ability to expedite shareholder value as we cultivate new opportunities alongside our current projects in New York, including:
160 Imlay street. Brooklyn Ny
8012 Tonelle Ave; North Bergen, NJ
44 Victory Blvd; Staten Island, NY
111 Station Road; Bellport, NY
15-17 Sherwood Ave - Yonkers Proposal
4290 Austin Blvd; Island Park, NY
"We have recently moved our headquarters to a functional work/living space which belongs to our flagship project at 160 Imlay Street in Brooklyn, New York, where our utility/financing model can be seen in action as we continue to develop opportunities in the NE United States and beyond."
Project To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_003full.jpg
"This is all in line with NY Governor Cuomo's recent announcement of a clean energy initiative which unveiled the details of the awards for 21 large-scale solar, wind, and energy storage projects across upstate New York, totaling 1,278 megawatts of new renewable capacity," states Fain.
Shareholders-visit greenrainsolar.com. where you can view Green Stream's news, filings and even a live Level 2 stream, along with other company information.
Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004.jpg GSFI - Strategic Moves To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004full.jpg
https://www.nasdaq.com/press-release/green-stream-holdings-anticipates-sunny-forecast-for-renewable-energy-market-rally-as
$MCET GOING UP TODAAAAAMOOOOOOOOOOOOOOOOON $$$$$$$$$$$
$MCET GOING UP TODAAAAAMOOOOOOOOOOOOOOOOON $$$$$$$$$$$